Plain-English translation of NCT05753826 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Neoplasms research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is an early-stage study testing a combination of two medications: and . Researchers want to see if giving these two drugs together can help women whose ovarian cancer has come back after platinum-based chemotherapy and is no longer responding to it. This is the first time doctors are exploring how well this particular pair of medications works together for this type of cancer.
Women whose ovarian cancer returns and becomes resistant to platinum chemotherapy have very limited treatment options. This medication combination may offer a new path forward by working in different ways to attack the cancer cells.
You likely qualify if…
You likely don't qualify if…
You would take both medications by mouth as directed by the study team. The study will track how well the medication combination works, whether your cancer shrinks, and what side effects you experience through regular visits and blood tests. Researchers will monitor your health closely throughout the study to make sure the treatment is safe and effective for you.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China